---
title: "Asian Growth Leaders With High Insider Ownership June 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290486739.md"
description: "Simply Wall St highlights Asian growth companies with high insider ownership, identifying potential market leaders. The report features a screener of 474 stocks and details specific picks like Hubei Wanrun New Energy, Jiangxi Fushine Pharmaceutical, and C Sun Mfg. These firms show strong earnings growth forecasts and improved profitability, though valuation reports suggest mixed price potentials relative to fair value estimates."
datetime: "2026-06-22T23:13:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290486739.md)
  - [en](https://longbridge.com/en/news/290486739.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290486739.md)
generator: "portal-rs"
---

# Asian Growth Leaders With High Insider Ownership June 2026

As global markets navigate shifting monetary policies and geopolitical developments, Asian equities have shown resilience, with particular strength in export-oriented sectors amid ongoing domestic challenges. In this environment, growth companies with high insider ownership can offer unique insights into potential market leaders, as insider confidence often aligns with strong business fundamentals.

### Top 10 Growth Companies With High Insider Ownership In Asia

**Name**

**Insider Ownership**

**Earnings Growth**

Zhejiang Taotao Vehicles (SZSE:301345)

27.9%

31.5%

Suzhou Dongshan Precision Manufacturing (SZSE:002384)

33.5%

68.4%

Shanghai Biren Technology (SEHK:6082)

11%

120.7%

Meitu (SEHK:1357)

22.8%

31.5%

Meiko Electronics (TSE:6787)

19.2%

27.3%

Guangzhou Tinci Materials Technology (SZSE:002709)

38.4%

28.6%

Great Microwave Technology (SHSE:688270)

21.1%

85.5%

Gold Circuit Electronics (TWSE:2368)

30.2%

38.2%

Fulin Precision (SZSE:300432)

10.4%

60.7%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

14.1%

40.4%

Click here to see the full list of 474 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

## Hubei Wanrun New Energy TechnologyLtd (SHSE:688275)

**Simply Wall St Growth Rating:** ★★★★★★

**Overview:** Hubei Wanrun New Energy Technology Co., Ltd. operates in the new energy sector with a market capitalization of CN¥16.76 billion.

**Operations:** The company generates revenue of CN¥14.59 billion from its production and sales of lithium-ion battery material products.

**Insider Ownership:** 33.1%

**Earnings Growth Forecast:** 57.2% p.a.

Hubei Wanrun New Energy Technology Ltd. showcases promising growth potential, with its revenue and earnings expected to grow significantly faster than the Chinese market. The company recently reported a substantial turnaround, achieving CNY 400.98 million in net income for Q1 2026 from a loss last year, indicating improved profitability. Despite interest payments not being well covered by earnings, the stock trades at good value compared to peers and benefits from high forecasted return on equity.

-   Unlock comprehensive insights into our analysis of Hubei Wanrun New Energy TechnologyLtd stock in this growth report.
-   Upon reviewing our latest valuation report, Hubei Wanrun New Energy TechnologyLtd's share price might be too pessimistic.

SHSE:688275 Earnings and Revenue Growth as at Jun 2026

## Jiangxi Fushine Pharmaceutical (SZSE:300497)

**Simply Wall St Growth Rating:** ★★★★★☆

**Overview:** Jiangxi Fushine Pharmaceutical Co., Ltd. operates in the research, development, production, and sale of APIs and pharmaceutical intermediates both in China and internationally, with a market cap of approximately CN¥10.49 billion.

**Operations:** The company's revenue is derived from the research, development, production, and sale of active pharmaceutical ingredients and pharmaceutical intermediates in both domestic and international markets.

**Insider Ownership:** 21.1%

**Earnings Growth Forecast:** 95.5% p.a.

Jiangxi Fushine Pharmaceutical demonstrates strong growth potential, with revenue forecasted to grow over 43% annually, outpacing the Chinese market. The company recently became profitable and reported significant earnings growth in Q1 2026, with net income rising to CNY 61.2 million from CNY 2.24 million a year ago. Despite high share price volatility and interest payments not well covered by earnings, it trades at a substantial discount to its estimated fair value.

-   Navigate through the intricacies of Jiangxi Fushine Pharmaceutical with our comprehensive analyst estimates report here.
-   Our valuation report unveils the possibility Jiangxi Fushine Pharmaceutical's shares may be trading at a premium.

SZSE:300497 Earnings and Revenue Growth as at Jun 2026

## C Sun Mfg (TWSE:2467)

**Simply Wall St Growth Rating:** ★★★★★☆

**Overview:** C Sun Mfg Ltd., along with its subsidiaries, offers a range of processing equipment in Taiwan, China, and globally, with a market cap of NT$88.63 billion.

**Operations:** The company's revenue is primarily generated from Csun Industrial with NT$4.18 billion, followed by Suzhou Top Creation Machines Co Ltd. at NT$2.19 billion, and C Sun Manufacturing LTD contributing NT$1.17 billion.

**Insider Ownership:** 11.4%

**Earnings Growth Forecast:** 40.5% p.a.

C Sun Mfg Ltd. exhibits strong growth prospects, with earnings expected to grow significantly at 40.5% annually, surpassing the Taiwanese market's average. Recent Q1 2026 results show substantial improvement, with net income rising to TWD 466.17 million from TWD 150.33 million year-on-year and sales increasing notably. Despite high share price volatility and trading slightly below fair value estimates, the company's revenue is forecasted to grow robustly at 27.5% per year, exceeding market averages.

-   Click here to discover the nuances of C Sun Mfg with our detailed analytical future growth report.
-   The valuation report we've compiled suggests that C Sun Mfg's current price could be inflated.

TWSE:2467 Earnings and Revenue Growth as at Jun 2026

## Summing It All Up

-   Unlock more gems! Our Fast Growing Asian Companies With High Insider Ownership screener has unearthed 471 more companies for you to explore.Click here to unveil our expertly curated list of 474 Fast Growing Asian Companies With High Insider Ownership.
-   Ready To Venture Into Other Investment Styles? Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.*

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [688275.CN](https://longbridge.com/en/quote/688275.CN.md)
- [300497.CN](https://longbridge.com/en/quote/300497.CN.md)
- [301345.CN](https://longbridge.com/en/quote/301345.CN.md)
- [002384.CN](https://longbridge.com/en/quote/002384.CN.md)
- [06082.HK](https://longbridge.com/en/quote/06082.HK.md)
- [01357.HK](https://longbridge.com/en/quote/01357.HK.md)
- [6787.JP](https://longbridge.com/en/quote/6787.JP.md)
- [002709.CN](https://longbridge.com/en/quote/002709.CN.md)
- [688270.CN](https://longbridge.com/en/quote/688270.CN.md)
- [300432.CN](https://longbridge.com/en/quote/300432.CN.md)
- [02315.HK](https://longbridge.com/en/quote/02315.HK.md)
- [688796.CN](https://longbridge.com/en/quote/688796.CN.md)

## Related News & Research

- [3 growth stocks down more than 50% from their highs](https://longbridge.com/en/news/296250934.md)
- [AI isn’t close to curing cancer. This startup says it knows what it will take.](https://longbridge.com/en/news/296352961.md)
- [02:05 ETRIMAN präsentiert Produkt- und Inhaltsstoffinnovationen auf der RIMAN North America Convention 2026](https://longbridge.com/en/news/296183241.md)
- [BioArctic, Mesenkia partner to develop BrainTransporter-enabled antibody for glioblastoma](https://longbridge.com/en/news/296330014.md)
- [Inhalation Sciences to present FDA-funded DissolvIt evaluation results at respiratory drug development conferences](https://longbridge.com/en/news/296444383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**